Hit enter to search or ESC to close

Home
About Us
Our Work
Our Products
Media / News
Contact
Orphalan Global
- #
  - Austria
  - Belgium
  - Brazil
  - China
  - Colombia
  - Croatia
  - Denmark
  - Ecuador
- #
  - Finland
  - France
  - Germany
  - Greece
  - Hungary
  - Ireland
  - Italy
  - Lithuania
- #
  - Luxembourg
  - Malta
  - Netherlands
  - New Zealand
  - Norway
  - Poland
  - Portugal
  - Saudi Arabia / Riyadh
- #
  - Slovenia
  - Spain
  - Switzerland
  - Sweden
  - UK
  - USA

Language
- Français
- English
search

Video

Dr. Naseem Amin, Chief Executive Officer at Orphalan, discusses the announcement of the FDA approval of Cuvrior™ Company News Video

Dr. Naseem Amin, Chief Executive Officer at Orphalan, discusses the announcement of the FDA approval of Cuvrior™

Dr. Naseem Amin, Chief Executive Officer at Orphalan, discusses the announcement of the FDA approval of Cuvrior™ in this video: https://www.youtube.com/watch?v=Yu2WsUwtayE

adminMay 3, 2022

Top line results of CHELATE trial presented at International Liver Congress 2021. Top line Summary by Michael Schilsky, MD Video

Top line results of CHELATE trial presented at International Liver Congress 2021. Top line Summary by Michael Schilsky, MD

adminJune 25, 2021

Disclaimer: This website is intended for global audience. The information available on this website is for information purposes only.

We work in a highly regulated industry with unique legal considerations. Medical and health information may be presented but the content we share is not intended to provide professional medical advice, diagnosis or treatment.

Always seek medical advice from a qualified health care professional for any questions you may have regarding your medical condition.

For any Medical Information requests, please contact the Orphalan Medical Information team using this email address : medicalquery@orphalan.com.

To report an adverse event experience for any Orphalan product please contact us by writing to AdverseEventReporting@orphalan.com or call direct: +356 2776 1718, or call the local toll free telephone number listed under your country and choosing option 3.

GL-ORPH-CORP-25018 Nov 2025

Global Headquarters

Orphalan SA
226 Boulevard Voltaire
75011 Paris
FRANCE
Email: info@orphalan.com
Tel : +33 (0)1 42 49 82 64

Legal

Cookie Policy
Privacy Policy
Terms of Use
Third-Party Code of Conduct

Useful Links

About Us
Careers
Contact
Our Research

linkedin
phone
email

Close Menu

Home
About Us
Our Work
Our Products
Media / News
Contact
Orphalan Global
- #
  - Austria
  - Belgium
  - Brazil
  - China
  - Colombia
  - Croatia
  - Denmark
  - Ecuador
- #
  - Finland
  - France
  - Germany
  - Greece
  - Hungary
  - Ireland
  - Italy
  - Lithuania
- #
  - Luxembourg
  - Malta
  - Netherlands
  - New Zealand
  - Norway
  - Poland
  - Portugal
  - Saudi Arabia / Riyadh
- #
  - Slovenia
  - Spain
  - Switzerland
  - Sweden
  - UK
  - USA
Language
- Français
- English